JP2024526324A5 - - Google Patents
Info
- Publication number
- JP2024526324A5 JP2024526324A5 JP2024501573A JP2024501573A JP2024526324A5 JP 2024526324 A5 JP2024526324 A5 JP 2024526324A5 JP 2024501573 A JP2024501573 A JP 2024501573A JP 2024501573 A JP2024501573 A JP 2024501573A JP 2024526324 A5 JP2024526324 A5 JP 2024526324A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence described
- binding moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163220842P | 2021-07-12 | 2021-07-12 | |
| US63/220,842 | 2021-07-12 | ||
| PCT/US2022/073567 WO2023288185A2 (en) | 2021-07-12 | 2022-07-08 | Bcma-directed cellular immunotherapy compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526324A JP2024526324A (ja) | 2024-07-17 |
| JP2024526324A5 true JP2024526324A5 (enExample) | 2026-04-23 |
Family
ID=84920530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501573A Pending JP2024526324A (ja) | 2021-07-12 | 2022-07-08 | Ｂｃｍａ指向性細胞免疫療法の組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250319185A1 (enExample) |
| EP (1) | EP4370554A4 (enExample) |
| JP (1) | JP2024526324A (enExample) |
| KR (1) | KR20240033025A (enExample) |
| CN (1) | CN117916267A (enExample) |
| AU (1) | AU2022310676A1 (enExample) |
| CA (1) | CA3224478A1 (enExample) |
| IL (1) | IL309436A (enExample) |
| MX (1) | MX2024000675A (enExample) |
| WO (1) | WO2023288185A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116355081A (zh) * | 2023-02-01 | 2023-06-30 | 清华大学 | 一种广谱中和SARS-CoV-2的中和抗体P2-1D5及其应用 |
| JP2026512487A (ja) | 2023-04-18 | 2026-04-16 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | Ｂｃｍａキメラ抗原受容体及びその使用 |
| WO2025171383A2 (en) | 2024-02-09 | 2025-08-14 | Dispatch Biotherapeutics, Inc. | Engineered cancer antigens and related methods and uses |
| WO2025171388A1 (en) | 2024-02-09 | 2025-08-14 | Dispatch Biotherapeutics, Inc. | Engineered cancer antigens with modified domains and related methods and uses |
| WO2026006767A1 (en) | 2024-06-28 | 2026-01-02 | Dispatch Biotherapeutics, Inc. | Tethered il-9/il-9r and related engineered cells and methods |
| WO2026072671A1 (en) | 2024-09-24 | 2026-04-02 | City Of Hope | Methods comprising oncolytic viruses expressing bcmat and bcma-targeted therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010054007A1 (en) * | 2008-11-07 | 2010-05-14 | Fabrus Llc | Combinatorial antibody libraries and uses thereof |
| SG11201704549UA (en) * | 2014-12-05 | 2017-07-28 | Memorial Sloan Kettering Cancer Center | Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof |
| US10882915B2 (en) * | 2017-10-24 | 2021-01-05 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of CD117+ cells |
| FI3749338T3 (fi) * | 2019-01-16 | 2024-07-29 | Caribou Biosciences Inc | Humanisoitu bcma vasta-aine ja bcma-car-t solut |
-
2022
- 2022-07-08 EP EP22843001.3A patent/EP4370554A4/en active Pending
- 2022-07-08 IL IL309436A patent/IL309436A/en unknown
- 2022-07-08 AU AU2022310676A patent/AU2022310676A1/en active Pending
- 2022-07-08 CN CN202280060013.0A patent/CN117916267A/zh active Pending
- 2022-07-08 WO PCT/US2022/073567 patent/WO2023288185A2/en not_active Ceased
- 2022-07-08 MX MX2024000675A patent/MX2024000675A/es unknown
- 2022-07-08 KR KR1020247004831A patent/KR20240033025A/ko active Pending
- 2022-07-08 US US18/578,164 patent/US20250319185A1/en active Pending
- 2022-07-08 CA CA3224478A patent/CA3224478A1/en active Pending
- 2022-07-08 JP JP2024501573A patent/JP2024526324A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518134A5 (enExample) | ||
| JP2022177090A5 (enExample) | ||
| CN110662771A (zh) | 一种结合bcma的嵌合抗原受体(car)及其应用 | |
| TWI754211B (zh) | 新型雙特異性cd3/cd20多肽複合物 | |
| JP2022523442A5 (enExample) | ||
| JP2019537433A5 (enExample) | ||
| JP2022514693A5 (enExample) | ||
| JP2021526844A5 (enExample) | ||
| TW202241956A (zh) | 新穎抗cd24抗體 | |
| JP2023093753A5 (enExample) | ||
| TW202428617A (zh) | 新型抗CD3ε抗體 | |
| JP2022533538A5 (enExample) | ||
| CN105073776A (zh) | 用于治疗表达紧密连接蛋白的癌症疾病的制剂 | |
| JP2025508343A5 (enExample) | ||
| JP2022542559A5 (enExample) | ||
| JP2023525695A5 (enExample) | ||
| CN111484555A (zh) | 新型双特异性cd3/cd20多肽复合物 | |
| JP2022534135A5 (enExample) | ||
| JP2022547552A5 (enExample) | ||
| JP2025038088A5 (enExample) | ||
| JP2020515277A5 (enExample) | ||
| JP2023545183A5 (enExample) | ||
| JP2024524301A5 (enExample) | ||
| JP2023545182A5 (enExample) | ||
| JP2024516098A5 (enExample) |